Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CRVS

Corvus Pharmaceuticals Inc

May 14 • 04:00PM ET

13.65

-2.19 -13.79 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: RCUS NRIX SNDX IOVA RLAY

| Held by: XBI VTI IWM VXF IWO IBB VTWO LFSC IWC VFMO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.53	Insider Own	23.76%	Shs Outstand	84.09M	Perf Week	-6.41%
Market Cap	1.15B	Forward P/E	-	EPS next Y	-0.74	Insider Trans	0.00%	Shs Float	64.11M	Perf Month	-9.63%
Enterprise Value	912.37M	PEG	-	EPS next Q	-0.15	Inst Own	39.31%	Short Float	28.68%	Perf Quarter	-27.21%
Income	-44.17M	P/S	-	EPS this Y	-232.77%	Inst Trans	7.45%	Short Ratio	14.47	Perf Half Y	67.14%
Sales	0.00M	P/B	4.77	EPS next Y	-16.79%	ROA	-28.26%	Short Interest	18.39M	Perf YTD	77.34%
Book/sh	2.86	P/C	4.85	EPS next 5Y	-	ROE	-30.46%	52W High	26.95 -49.33%	Perf Year	277.21%
Cash/sh	2.81	P/FCF	-	EPS past 3/5Y	15.40% -21.44%	ROIC	-18.32%	52W Low	3.38 303.99%	Perf 3Y	566.10%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.45% 7.83%	Perf 5Y	446.20%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	17.91%	Oper. Margin	-	ATR (14)	1.19	Perf 10Y	28.10%
Dividend Ex-Date	-	Quick Ratio	19.81	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	39.57	Recom	1.14
Dividend Gr. 3/5Y	- -	Current Ratio	19.81	EPS Q/Q	-15.05%	SMA20	-13.18%	Beta	0.92	Target Price	33.33
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-10.36%	Rel Volume	3.10	Prev Close	15.84
Employees	37	LT Debt/Eq	0.00	Earnings	May 07 AMC	SMA200	24.19%	Avg Volume	1.27M	Price	13.65
IPO	Mar 23, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.34% -	Trades		Volume	3,945,210	Change	-13.79%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)